Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway

Xuenan Liu(Peking University), Yongsheng Zhou(King University)
Stem Cell Research & Therapy
July 19, 2019
Cited by 28


Related Papers